Future of Work related patent filings decreased in the pharmaceutical industry in Q2 2023

Notably, the number of future of work-related patent applications in the pharmaceutical industry was 448 in Q2 2023, versus 599 in the prior quarter.

The top five companies accounted for 5% of patenting activity

Analysis of patenting activity by companies shows that Chinese Academy of Sciences filed the most future of work patents within the pharmaceutical industry in Q2 2023. The company filed 6 future of work-related patents in the quarter, compared with 3 in the previous quarter. It was followed by Sun Yat-sen University with 5 future of work patent filings, Ori Biotech (4 filings), and Danaher (4 filings) in Q2 2023.

Patenting activity was driven by China with a 44% share of total patent filings

The largest share of future of work related patent filings in the pharmaceutical industry in Q2 2023 was in China with 44%, followed by the US (28%) and Japan (5%). The share represented by China was 4% lower than the 48% share it accounted for in Q1 2023.

For further understanding of GlobalData’s Future of Work – Thematic Research buy the report here.

Subscribe to our Newsletter

Get industry leading news, data and analysis delivered to your inbox

Subscribe

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.